The company "OKO-VITA" Poland Sp. z o. o.

offers comprehensive services related to the sale and service of highly specialized medical equipment and medical supplies.

The activity started his in 1995 initially dealing with the distribution of preparations, "OPTI-FREE" Alcon Pharmaceuticals Ltd for the care of contact lenses. Since February 1996 we have a license to run a pharmaceutical warehouse. Since then, the company offers is widening. Currently we specialize in the supply of intraocular lenses, the operating fluid, ophthalmic sutures and operating equipment. Since 2000, our company is the exclusive representative of the company AMO (USA) and Dr. Schmidt (Germany) on the Polish market.

Currently we supply lenses for implants, materials and highly specialized operating medical devices to over 50 branches of ophthalmology in the country.
We work closely with over 200 offices throughout the ophthalmic Polish in skills for modern surgery with intraocular lenses.

The greatest value of the company is not only our intellectual potential that we have collected over the years, but close cooperation with various actors in the market. We work closely with NZOZ Bopol - private center offering specialized medical services in the field of ophthalmology. NZOZ Bopol is the only center in Poland wszczepiającym accommodative lenses, multifocal and toric, performs over 2,500 procedures to remove cataracts annually. We look forward to recognizing many clinical centers and the ophthalmic hospitals both public and private as evidenced received letters and testimonials.

About our performance is reflected in the fact that at the annual conference of representatives and distributors of AMO in 2003, received the award for the biggest increase in sales of silicone lenses in the world.
The company's eye-vita reputation as a reliable partner in the ophthalmic market, providing services at the highest level. Planned implementation of the production of highly specialized medical devices and ophthalmic technology Institute, will be a decisive step into the future, which will allow us to develop wysokokonkurencynym European Union market.